Guided Therapeutics organizacji Net debt/EBITDA
Jaka jest wartość Net debt/EBITDA organizacji Guided Therapeutics?
Wartość Net debt/EBITDA organizacji Guided Therapeutics, Inc. to -0.52
Jaka jest definicja Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA firm w Health Care sektor na OTC w porównaniu do Guided Therapeutics
Czym się zajmuję organizacja Guided Therapeutics?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Firmy z net debt/ebitda podobne do Guided Therapeutics
- Wartość Net debt/EBITDA organizacji Visteon to -0.52
- Wartość Net debt/EBITDA organizacji Bouvet ASA to -0.52
- Wartość Net debt/EBITDA organizacji TOT BIOPHARM International to -0.52
- Wartość Net debt/EBITDA organizacji Coolpad to -0.52
- Wartość Net debt/EBITDA organizacji Franchise International to -0.52
- Wartość Net debt/EBITDA organizacji Vanadiumcorp Resource to -0.52
- Wartość Net debt/EBITDA organizacji Guided Therapeutics to -0.52
- Wartość Net debt/EBITDA organizacji Mandalay Resources to -0.52
- Wartość Net debt/EBITDA organizacji Midnight Sun Mining to -0.51
- Wartość Net debt/EBITDA organizacji Sonoro Gold to -0.51
- Wartość Net debt/EBITDA organizacji McEwen Mining to -0.51
- Wartość Net debt/EBITDA organizacji SKY Network Television to -0.51
- Wartość Net debt/EBITDA organizacji Old Dominion Freight Line to -0.51